True North BioPharm delivers actionable intelligence based on deep scientific expertise to help clients select the most appropriate enabling technologies and nonclinical model platforms for drug development, guide the design of studies to bridge preclinical data to clinical expectations, and make data-driven go/no-go decisions at each point in the life cycle of medical countermeasure (MCM) development.

True North BioPharm knows the importance of ensuring every study is carefully designed to generate meaningful data and minimizes overall risk to MCM development programs in the form of time and money. True North BioPharm helps clients trust the data generated through the recommendation of independently qualified laboratories, advising on the selection of models most suitable for MCM development, and providing expert scientific review of study protocols and final reports. To ensure our clients’ trust, True North BioPharm does not take any fees from matching product developers with independent academic and contract research organization vendors.